首页 | 本学科首页   官方微博 | 高级检索  
检索        


Cost implications of implementation of pathogen‐inactivated platelets
Authors:Jeffrey McCullough  Dennis Goldfinger  Jed Gorlin  William J Riley  Harpreet Sandhu  Christopher Stowell  Dawn Ward  Mary Clay  Shelley Pulkrabek  Vera Chrebtow  Adonis Stassinopoulos
Institution:1. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota;2. Department of Laboratory Medicine and Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California;3. Memorial Blood Centers/Innovative Blood Resources, St Paul, Minnesota;4. College of the Science of Health Care Delivery, Arizona State University, Tempe, Arizona;5. Stanford Blood Center, Stanford University School of Medicine, Stanford, California;6. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;7. Global Scientific Affairs, Cerus Corporation, Concord, California
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号